Posted on

BioSurplus Announces Collaboration With BaneBio

Earlier this week, we were pleased to unveil our collaboration with BioSurplus. This relationship establishes an East Coast base of operations for BioSurplus that will optimize returns for companies seeking to sell their surplus. The collaboration will also help lower shipping costs for customers purchasing equipment in the eastern half of the U.S.

Continue reading BioSurplus Announces Collaboration With BaneBio

Posted on

Have You Heard the News? We’ve Changed Our Name!

bane-bio-team

 

Press Release: ReGen Lab Equipment, LLC Announces Corporate Name Change to BaneBio, LLC

FREDERICK, MD – SEPTEMBER 15, 2016

In response to a recent expansion of our product and service offerings to the life sciences community, ReGen Lab Equipment, LLC announced Thursday, September 15 that it will change its name to BaneBio, LLC.

Continue reading Have You Heard the News? We’ve Changed Our Name!

Posted on

New Gene Identified As Cause, Early Indicator of Breast Cancer

scientists in a lab
In March, studies conducted at the Medical College of Georgia at Augusta University learned “when mutated, a gene known for its ability to repair DNA, appears to instead cause breast cancer, scientists report”. These studies, published in the American Journal of Pathology, were performed on an international sampling from 254 cases of breast cancer in pre- and postmenopausal women. Continue reading New Gene Identified As Cause, Early Indicator of Breast Cancer

Posted on

The First FDA-Approved Drug Manufactured Using 3D Printing

The first prescription drug manufactured using 3D printing technology has been approved by the FDA. Aprecia Pharmaceuticals’ SPRITAM tablets for oral suspension are now available for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. SPRITAM drug disintegrates in the mouth with liquid. Continue reading The First FDA-Approved Drug Manufactured Using 3D Printing